Condition
IRIS
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07565623Not ApplicableNot Yet Recruiting
Prevention of AIDS With Opportunistic Infection Paradoxical IRIS
NCT03092817Phase 3Completed
Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
NCT05484050Not ApplicableUnknownPrimary
VEGF in Iris Tissue in Primary Congenital Glaucoma
NCT01240486CompletedPrimary
IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Showing all 4 trials